DMA4-H228
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
DM3-BTA-14 is a cationic lipid compound engineered for high-efficiency mRNA delivery developed by Hefei AlphaNA Biotechnology. Its structure features a rigid benzene-1,3,5-tricarboxamide core linked to a protonatable dimethylamino headgroup (-N(CH₃)₂) via a propylene spacer (-CH₂CH₂CH₂-) and two saturated C14 alkyl chains. This design enables ≈90% endosomal escape efficiency , superior lymph node targeting for vaccines , and effective tumor-specific mRNA delivery . It outperforms benchmark lipids while maintaining low cytotoxicity, forming stable nanoparticles with cholesterol/DSPC/DSPE-PEG (50:39:10:1 ratio) for therapeutic applications.
| CAS No. | Not available |
| Chemical Name | DM3-BTA-14 |
| Synonyms | DM3BTA14, DM3 BTA 14 |
| SMILES | CCCCCCCCCCCCCCOC(=O)C1=CC(C(=O)OCCCCCCCCCCCCCC)=CC(C(=O)NCCCNC)=C1 |
| Formula | C41H72O5N2 |
| M.Wt | 672.54 |
| Purity | ELSD-HPLC>95% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 14.8690 mL | 2.9738 mL | 1.4869 mL |
| 25 mg | 37.1725 mL | 7.4345 mL | 3.7173 mL |
| 50 mg | 74.3450 mL | 14.8690 mL | 7.4345 mL |
| 100 mg | 148.6900 mL | 29.7380 mL | 14.8690 mL |
| 250 mg | 371.7251 mL | 74.3450 mL | 37.1725 mL |
Contact our team with the catalog number and requested quantity.